HCA Holdings Inc (HCA)

Nov 3, 2026

HealthSource of Ohio has secured financing for a new $60 million medical facility in Batavia, Clermont County, with Fifth Third Bank providing the funding. The facility, which is a partnership between HealthSource of Ohio and UC Health, broke ground on October 20th. This development will expand medical services in the region.

Nov 3, 2026

Royal Philips reported an 8% comparable order intake growth for Q3 2026, driven by its Diagnosis & Treatment segment, with comparable sales up 3% to EUR 4.4 billion. The company reiterated its 2026 outlook and recorded a EUR 288 million provision following an agreement in principle with the US Department of Justice regarding previously disclosed Respironics recall investigations. This settlement is expected to be paid in Q1 2027, subject to final documentation.

Nov 2, 2026

Bon Secours Mercy Health, through its affiliate HealthSpan Partners, has agreed to acquire Surgery Partners in a $5.7 billion deal, taking the surgery center chain private. This acquisition, expected to close in Q1 2027, will significantly expand Bon Secours' presence in the outpatient surgery market, building on Surgery Partners' $3.31 billion revenue in 2025. The deal is partly financed by new debt and sees Bain Capital, a current minority owner, rolling its 39% stake into HealthSpan Partners equity, maintaining a significant involvement.

Nov 2, 2026

Acadia Healthcare (ACHC) is scheduled to report earnings after market close this Wednesday. The company previously beat revenue expectations and met full-year guidance, with analysts reconfirming estimates for the upcoming quarter. While Acadia Healthcare has missed revenue estimates in the past, the hospital chains segment, including peers like Tenet Healthcare and HCA Healthcare, has shown positive sentiment recently.

Nov 2, 2026

Marriott International (MAR) reported strong third-quarter results, with revenue per available room (revPAR) increasing by 6.5% and adjusted EBITDA growing by 12%. The company has raised its 2026 revPAR growth forecast to 4.5%-5.0% and expects 3.5%-4.0% growth in 2027, driven by healthy travel demand. Analyst Dan Wasiolek notes that Marriott's brand advantage remains intact, though shares are considered rich.

Oct 31, 2026

Tenet Healthcare Corporation announced strong third-quarter 2026 results, with net income available to common shareholders reaching $1 billion, or $12.41 per diluted share. The company also raised its full-year 2026 financial outlook, with Adjusted EBITDA now expected to be between $5.05 billion and $5.20 billion, and Adjusted Free Cash Flow projected to be between $2.825 billion and $3.125 billion. This outperformance was attributed to robust same-store revenue growth and efficient expense management across its Ambulatory Care and Hospital Operations segments.

Oct 30, 2026

HCA Healthcare Inc. reported lobbying on the Patients Deserve Price Tags Act, a Senate bill requiring hospitals to publicly disclose prices. The company's in-house lobbying expenses increased significantly, totaling $1.73 million for the third quarter, plus an additional $80,000 from an outside firm. HCA also lobbied on other healthcare legislation, including the Prices on the Wall Act of 2026 and the Health Care Affordability Act of 2025.

Oct 30, 2026

Shares of HCA Healthcare Inc. (HCA) fell 1.02% on Friday, underperforming major market indexes like the S&P 500 and Dow Jones Industrial Average, which also saw declines. This drop broke a two-day winning streak for the stock.

Oct 30, 2026

ResMed Inc. (NYSE:RMD) has announced a quarterly dividend of $0.66 per share, to be paid on December 17th to shareholders of record on November 12th. This dividend represents an annualized payout of $2.64 and a 1.0% yield, well-covered by earnings with a 25% payout ratio. The company has a history of increasing its dividend for 13 consecutive years and recently exceeded quarterly earnings expectations with $2.91 EPS and $1.41 billion in revenue.

Oct 29, 2026

Medical Properties Trust (MPT) reported strong Q3 2026 results, with normalized funds from operations EPS of $0.11, significantly beating Wall Street estimates of -$0.01. The healthcare REIT's revenue increased by 5.3% year-over-year to $250.1 million, and it returned to profitability with a net income of $202.1 million. Despite the positive earnings, the stock saw a muted reaction, indicating investor caution regarding longer-term outlooks for dividend sustainability and portfolio quality.

Oct 29, 2026

Tenet Healthcare reported strong third-quarter 2026 results, with net operating revenues reaching $5.63 billion and adjusted earnings per share of $6.64, significantly exceeding analyst estimates. This performance, driven by growth in both its hospital and ambulatory businesses, led the company to raise its 2026 adjusted EBITDA guidance by $195 million and express confidence in continued earnings growth in 2027. Executives highlighted rising hospital activity, expense reductions, and strategic focus on high-acuity patients in the ambulatory segment.

Oct 29, 2026

Community Health Systems (CHS) missed its third-quarter financial targets, attributing the shortfall to federal policy changes and unfavorable shifts in payer mix, challenges currently affecting health systems nationwide. The article highlights these issues as part of a broader trend impacting the healthcare industry. It also lists related articles, suggesting a pattern of financial struggles and strategic adjustments within CHS and other major healthcare providers like HCA.

Oct 29, 2026

HCA Healthcare Inc. (HCA) shares rose 3.21% to $478.08 on Thursday, outperforming the broader market during a challenging trading session where the S&P 500 Index and Dow Jones Industrial Average both declined. This marks the second consecutive day of gains for HCA Healthcare's stock.

Oct 29, 2026

HCA Healthcare's Q3 2026 results exceeded Wall Street expectations, driven by volume growth and cost management. The article highlights five key analyst questions from the earnings call, covering topics like public exchange headwinds, 340B reallocation benefits, elective surgery demand, and the application of resiliency programs. Management provided insights into these areas, emphasizing ongoing strategic initiatives and challenges like affordability pressures.

Oct 28, 2026

HCA Healthcare Inc. (HCA) shares rose 2.95% to $463.22, outperforming the broader market indexes like the S&P 500 and Dow Jones Industrial Average on a strong trading day. This increase ended a two-day losing streak for the company's stock.

Oct 27, 2026

National HealthCare Corporation's shares fell 5.2% on Tuesday, closing at $211.97, as a broad selloff impacted the healthcare facilities sector. The decline, which also affected peers like Universal Health Services and Acadia Healthcare, was driven by sector-wide pressure rather than company-specific news. Investors are now questioning whether this represents a temporary rotation or the start of sustained pressure on medical care facility operators.

Oct 27, 2026

HCA Healthcare reported strong third-quarter 2026 results, surpassing Wall Street estimates for both revenue and adjusted earnings, with revenues of $19.849 billion and adjusted earnings of $7.22. However, the stock experienced a downturn due to a $400 million unfavorable impact on income before taxes caused by a payer mix shift towards uninsured patients, primarily from health insurance exchanges. Despite this challenge, the company raised its fiscal 2026 guidance for both earnings and sales, anticipating continued demand for services in 2027.

Oct 27, 2026

HCA Healthcare's stock traded lower despite better-than-expected Q3 2026 results after the company reaffirmed its full-year outlook. As the hospital sector's bellwether, HCA's performance also led to declines among its peers, including Community Health Systems (CYH). The article highlights the immediate market reaction to HCA's earnings report and its broader impact on the hospital industry.

Oct 27, 2026

HCA Healthcare reported a 3% increase in adjusted admissions and a 4% rise in diluted earnings per share for Q3 2026, marking 22 consecutive quarters of volume growth. The company anticipates a $550-$650 million reduction in Medicaid supplemental payments for 2027 and expects consistent earnings compared to 2026, driven by continued volume growth of 2-3% and ongoing strategic initiatives like digital transformation and network development. Management expressed confidence in achieving long-term objectives through strong core performance and resiliency programs aimed at cost management.

Oct 27, 2026

Royal Caribbean Group reported strong Q3 2026 results, exceeding expectations with a 9% year-over-year revenue increase and earnings 4% above guidance, leading to an increased full-year outlook. The company announced a strategic $3 billion acquisition of a 50% stake in Sandals and Beaches Resorts, aiming to expand its integrated vacation ecosystem and capture a larger share of the growing all-inclusive market. Management highlighted strong booking volumes for 2026 and 2027, driven by high customer satisfaction and strategic investments in loyalty programs and technology, reinforcing confidence in future growth and shareholder returns.

Oct 27, 2026

HCA Healthcare exceeded Wall Street expectations for its third-quarter results due to strong demand for medical services, despite an increase in uninsured patients impacting income. The company now anticipates its full-year 2026 financial performance to be in the upper half of its previously forecast range, with significant growth in admissions and revenue. This positive outlook comes despite federal policy changes that have led to more patients losing health insurance coverage.

Oct 27, 2026

HCA Healthcare exceeded third-quarter profit estimates due to strong patient traffic and unexpected Medicaid supplemental payments, which helped offset a rise in uninsured patients. Despite a decrease in surgical procedures, cost controls and increased equivalent admissions contributed to the positive results. The company now anticipates full-year financial results to be in the upper half of its forecast range.

Oct 27, 2026

HCA Healthcare exceeded Wall Street's profit estimates for the third quarter, driven by strong demand for medical services despite an increase in uninsured patients. The hospital operator reported an adjusted profit of $7.22 per share, surpassing estimates of $6.66 per share, and revenue rose 3.6% to $19.85 billion, also above predictions.

Oct 27, 2026

HCA Healthcare surpassed Wall Street's third-quarter profit estimates due to strong demand for medical services, despite an increase in uninsured patients. The hospital operator reported an adjusted profit of $7.22 per share, exceeding analyst estimates of $6.66, and revenue rose 3.6% to $19.85 billion, also above expectations.

Oct 27, 2026

DaVita (DVA) stock saw a significant rise of 71.6% from January to October 2026, driven by higher profit forecasts in its February and May quarterly reports. However, the gains were partly offset after its August report, which indicated a decrease in revenue per treatment due to patients leaving Obamacare plans. Despite the stock's volatility, the company's net income and operating margin remained relatively flat, with per-share profit growth primarily attributable to share buybacks and a reduced share count rather than substantial operational improvements.

Oct 27, 2026

HCA Healthcare Inc. (HCA) reported strong third-quarter results, with net income of $1.58 billion, or $7.27 per share, exceeding Wall Street expectations. Adjusted earnings per share were $7.22, surpassing the average analyst estimate of $6.74. The hospital operator also reported revenue of $19.85 billion, beating forecasts, and provided a positive full-year earnings outlook.

Oct 27, 2026

HCA Healthcare exceeded Wall Street's third-quarter profit estimates due to strong demand for medical services, despite an increase in uninsured patients. The hospital operator's shares rose, and the company now expects its full-year 2026 financial results to be in the upper half of its previously forecast range. Revenue and admissions also increased, signaling a positive outlook for the company despite challenges from federal policy changes.